WHO ICTRP trial
To evaluate effect of KSM-66 Ashwagandha® Capsule (300 mg) in Management of…
CTRI/2022/02/040554 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2022/02/040554 |
|---|---|
| Public title | To evaluate effect of KSM-66 Ashwagandha® Capsule (300 mg) in Management of Frailty in Older Adults |
| Scientific title | A Double Blind, Randomized, Parallel, Single-Center, Two-Arm, Placebo Controlled Clinical Study to Assess the Efficacy and Safety of KSM-66 Ashwagandha® Capsule (300 mg) in Management of Frailty in Older Adults |
| Primary sponsor | Ixoreal Biomed |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Registration date | Feb 23, 2022 |
| Target size | 50 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: